findmyKOL
Clinical trialNCT05956587RecruitingPhase 2Interventional

A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

SponsorSichuan Baili Pharmaceutical Co., Ltd.Enrollment121Nasopharyngeal CarcinomaNon-small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, China

    Not, yet, recruiting
  • Fujian Cancer Hospital

    Fuzhou, Fujian, China

    Not, yet, recruiting
  • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • the First Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • Liuzhou People'S Hospital

    Liuzhou, Guangxi, China

    Not, yet, recruiting
  • the First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China

    Not, yet, recruiting
  • Henan Cancer Hospital

    Zhengzhou, Henan, China

    Not, yet, recruiting
  • Union Hospital Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

    Not, yet, recruiting
  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China

    Not, yet, recruiting
  • Hunan Cancer Hospita

    Changsha, Hunan, China

    Not, yet, recruiting
  • the Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

    Not, yet, recruiting
  • Linyi Cancer Hospital

    Linyi, Shangdong, China

    Recruiting
  • the First Affiliated Hospital of Xi'An Jiao Tong University

    Xi’an, Shanxi, China

    Not, yet, recruiting
  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

    Not, yet, recruiting
  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jan 2024
Primary completion
31 Dec 2026
Completion
31 Dec 2027
Last update posted
26 Sept 2025
Registered enrollment
121
Registry id
NCT05956587

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.